Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil target concentrations and sevoflurane MACBAR in laparoscopic surgery patients with grade B liver function
ChiCTR1800019026Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and sevoflurane (3 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Heart rate. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
remifentanilsevoflurane
Beyond the preview
Go deeper on ChiCTR1800019026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019026.